PUBLISHER: Lucintel | PRODUCT CODE: 1437726
PUBLISHER: Lucintel | PRODUCT CODE: 1437726
Cancer Immunotherapy Trends and Forecast
The future of the global cancer immunotherapy market looks promising with opportunities in the hospital, cancer research center, and clinic markets. The global cancer immunotherapy market is expected to reach an estimated $162.4 billion by 2030 with a CAGR of 10.4% from 2024 to 2030. The major drivers for this market are rising incidence of cancer conditions, introduction of biosimilars, and growing demand for mAbs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cancer Immunotherapy by Segment
The study includes a forecast for the global cancer immunotherapy by technology type, application, end use, and region.
List of Cancer Immunotherapy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer immunotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer immunotherapy companies profiled in this report include-
Cancer Immunotherapy Market Insights
Lucintel forecasts that lung will remain the largest segment over the forecast period.
Within this market, hospital will remain the largest segment over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Cancer Immunotherapy Market
Market Size Estimates: Cancer immunotherapy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cancer immunotherapy market size by technology type, application, end use, and region in terms of value ($B).
Regional Analysis: Cancer immunotherapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technology types, applications, end uses, and regions for the cancer immunotherapy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer immunotherapy market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the cancer immunotherapy market size?
Answer: The global cancer immunotherapy market is expected to reach an estimated $162.4 billion by 2030.
Q2. What is the growth forecast for cancer immunotherapy market?
Answer: The global cancer immunotherapy market is expected to grow with a CAGR of 10.4% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the cancer immunotherapy market?
Answer: The major drivers for this market are rising incidence of cancer conditions, introduction of biosimilars and growing demand for mAbs.
Q4. What are the major segments for cancer immunotherapy market?
Answer: The future of the cancer immunotherapy market looks promising with opportunities in the hospital, cancer research center, and clinic markets.
Q5. Who are the key cancer immunotherapy market companies?
Answer: Some of the key cancer immunotherapy companies are as follows:
Q6. Which cancer immunotherapy market segment will be the largest in future?
Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.
Q7. In cancer immunotherapy market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.